Stock Price
47.42
Daily Change
0.64 1.37%
Monthly
0.13%
Yearly
-19.76%
Q1 Forecast
44.95

Recordati reported EUR171.38M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
GlaxoSmithKline GBP 2.16B 19M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Orion EUR 84.6M 12.1M Sep/2025
Sanofi EUR 2.75B 455M Dec/2025